The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Streptokinase Market Research Report 2024
Synopsis
Streptokinase is indicated for the treatment of AMI, acute massive pulmonary embolism (PE), deep vein thrombosis (DVT), arterial thrombosis, and occluded arteriovenous cannulae.
The global Streptokinase market was valued at US$ 364 million in 2023 and is anticipated to reach US$ 526.1 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
North American market for Streptokinase is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Streptokinase is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Streptokinase include SAMARTH PHARMA, Biocon, Kee Pharma, Dabur, Biosena, Wanbang Biopharma, Qingdao GD Biotechnology Pharmaceutical, Aristo Pharmaceuticals and Neiss Labs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Streptokinase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Streptokinase.
Report Scope
The Streptokinase market size, estimations, and forecasts are provided in terms of sales volume (Million IU) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Streptokinase market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Streptokinase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
SAMARTH PHARMA
Biocon
Kee Pharma
Dabur
Biosena
Wanbang Biopharma
Qingdao GD Biotechnology Pharmaceutical
Aristo Pharmaceuticals
Neiss Labs
Ahaan Healthcare Pvt Ltd. (AHPL)
Biofactor
TTK HealthCare
Incepta Pharmaceuticals Limited
Cadila
Segment by Type
High IU
Low IU
Segment by Application
Myocardial Infarction (MI)
Deep Vein Thrombosis
Pulmonary Embolism
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Streptokinase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Streptokinase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Streptokinase is indicated for the treatment of AMI, acute massive pulmonary embolism (PE), deep vein thrombosis (DVT), arterial thrombosis, and occluded arteriovenous cannulae.
The global Streptokinase market was valued at US$ 364 million in 2023 and is anticipated to reach US$ 526.1 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
North American market for Streptokinase is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Streptokinase is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Streptokinase include SAMARTH PHARMA, Biocon, Kee Pharma, Dabur, Biosena, Wanbang Biopharma, Qingdao GD Biotechnology Pharmaceutical, Aristo Pharmaceuticals and Neiss Labs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Streptokinase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Streptokinase.
Report Scope
The Streptokinase market size, estimations, and forecasts are provided in terms of sales volume (Million IU) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Streptokinase market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Streptokinase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
SAMARTH PHARMA
Biocon
Kee Pharma
Dabur
Biosena
Wanbang Biopharma
Qingdao GD Biotechnology Pharmaceutical
Aristo Pharmaceuticals
Neiss Labs
Ahaan Healthcare Pvt Ltd. (AHPL)
Biofactor
TTK HealthCare
Incepta Pharmaceuticals Limited
Cadila
Segment by Type
High IU
Low IU
Segment by Application
Myocardial Infarction (MI)
Deep Vein Thrombosis
Pulmonary Embolism
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Streptokinase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Streptokinase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Streptokinase Market Overview
1.1 Product Overview and Scope of Streptokinase
1.2 Streptokinase Segment by Type
1.2.1 Global Streptokinase Market Value Comparison by Type (2024-2030)
1.2.2 High IU
1.2.3 Low IU
1.3 Streptokinase Segment by Application
1.3.1 Global Streptokinase Market Value by Application: (2024-2030)
1.3.2 Myocardial Infarction (MI)
1.3.3 Deep Vein Thrombosis
1.3.4 Pulmonary Embolism
1.3.5 Others
1.4 Global Streptokinase Market Size Estimates and Forecasts
1.4.1 Global Streptokinase Revenue 2019-2030
1.4.2 Global Streptokinase Sales 2019-2030
1.4.3 Global Streptokinase Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Streptokinase Market Competition by Manufacturers
2.1 Global Streptokinase Sales Market Share by Manufacturers (2019-2024)
2.2 Global Streptokinase Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Streptokinase Average Price by Manufacturers (2019-2024)
2.4 Global Streptokinase Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Streptokinase, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Streptokinase, Product Type & Application
2.7 Streptokinase Market Competitive Situation and Trends
2.7.1 Streptokinase Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Streptokinase Players Market Share by Revenue
2.7.3 Global Streptokinase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Streptokinase Retrospective Market Scenario by Region
3.1 Global Streptokinase Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Streptokinase Global Streptokinase Sales by Region: 2019-2030
3.2.1 Global Streptokinase Sales by Region: 2019-2024
3.2.2 Global Streptokinase Sales by Region: 2025-2030
3.3 Global Streptokinase Global Streptokinase Revenue by Region: 2019-2030
3.3.1 Global Streptokinase Revenue by Region: 2019-2024
3.3.2 Global Streptokinase Revenue by Region: 2025-2030
3.4 North America Streptokinase Market Facts & Figures by Country
3.4.1 North America Streptokinase Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Streptokinase Sales by Country (2019-2030)
3.4.3 North America Streptokinase Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Streptokinase Market Facts & Figures by Country
3.5.1 Europe Streptokinase Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Streptokinase Sales by Country (2019-2030)
3.5.3 Europe Streptokinase Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Streptokinase Market Facts & Figures by Country
3.6.1 Asia Pacific Streptokinase Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Streptokinase Sales by Country (2019-2030)
3.6.3 Asia Pacific Streptokinase Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Streptokinase Market Facts & Figures by Country
3.7.1 Latin America Streptokinase Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Streptokinase Sales by Country (2019-2030)
3.7.3 Latin America Streptokinase Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Streptokinase Market Facts & Figures by Country
3.8.1 Middle East and Africa Streptokinase Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Streptokinase Sales by Country (2019-2030)
3.8.3 Middle East and Africa Streptokinase Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Streptokinase Sales by Type (2019-2030)
4.1.1 Global Streptokinase Sales by Type (2019-2024)
4.1.2 Global Streptokinase Sales by Type (2025-2030)
4.1.3 Global Streptokinase Sales Market Share by Type (2019-2030)
4.2 Global Streptokinase Revenue by Type (2019-2030)
4.2.1 Global Streptokinase Revenue by Type (2019-2024)
4.2.2 Global Streptokinase Revenue by Type (2025-2030)
4.2.3 Global Streptokinase Revenue Market Share by Type (2019-2030)
4.3 Global Streptokinase Price by Type (2019-2030)
5 Segment by Application
5.1 Global Streptokinase Sales by Application (2019-2030)
5.1.1 Global Streptokinase Sales by Application (2019-2024)
5.1.2 Global Streptokinase Sales by Application (2025-2030)
5.1.3 Global Streptokinase Sales Market Share by Application (2019-2030)
5.2 Global Streptokinase Revenue by Application (2019-2030)
5.2.1 Global Streptokinase Revenue by Application (2019-2024)
5.2.2 Global Streptokinase Revenue by Application (2025-2030)
5.2.3 Global Streptokinase Revenue Market Share by Application (2019-2030)
5.3 Global Streptokinase Price by Application (2019-2030)
6 Key Companies Profiled
6.1 SAMARTH PHARMA
6.1.1 SAMARTH PHARMA Corporation Information
6.1.2 SAMARTH PHARMA Description and Business Overview
6.1.3 SAMARTH PHARMA Streptokinase Sales, Revenue and Gross Margin (2019-2024)
6.1.4 SAMARTH PHARMA Streptokinase Product Portfolio
6.1.5 SAMARTH PHARMA Recent Developments/Updates
6.2 Biocon
6.2.1 Biocon Corporation Information
6.2.2 Biocon Description and Business Overview
6.2.3 Biocon Streptokinase Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Biocon Streptokinase Product Portfolio
6.2.5 Biocon Recent Developments/Updates
6.3 Kee Pharma
6.3.1 Kee Pharma Corporation Information
6.3.2 Kee Pharma Description and Business Overview
6.3.3 Kee Pharma Streptokinase Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Kee Pharma Streptokinase Product Portfolio
6.3.5 Kee Pharma Recent Developments/Updates
6.4 Dabur
6.4.1 Dabur Corporation Information
6.4.2 Dabur Description and Business Overview
6.4.3 Dabur Streptokinase Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dabur Streptokinase Product Portfolio
6.4.5 Dabur Recent Developments/Updates
6.5 Biosena
6.5.1 Biosena Corporation Information
6.5.2 Biosena Description and Business Overview
6.5.3 Biosena Streptokinase Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biosena Streptokinase Product Portfolio
6.5.5 Biosena Recent Developments/Updates
6.6 Wanbang Biopharma
6.6.1 Wanbang Biopharma Corporation Information
6.6.2 Wanbang Biopharma Description and Business Overview
6.6.3 Wanbang Biopharma Streptokinase Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Wanbang Biopharma Streptokinase Product Portfolio
6.6.5 Wanbang Biopharma Recent Developments/Updates
6.7 Qingdao GD Biotechnology Pharmaceutical
6.6.1 Qingdao GD Biotechnology Pharmaceutical Corporation Information
6.6.2 Qingdao GD Biotechnology Pharmaceutical Description and Business Overview
6.6.3 Qingdao GD Biotechnology Pharmaceutical Streptokinase Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qingdao GD Biotechnology Pharmaceutical Streptokinase Product Portfolio
6.7.5 Qingdao GD Biotechnology Pharmaceutical Recent Developments/Updates
6.8 Aristo Pharmaceuticals
6.8.1 Aristo Pharmaceuticals Corporation Information
6.8.2 Aristo Pharmaceuticals Description and Business Overview
6.8.3 Aristo Pharmaceuticals Streptokinase Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aristo Pharmaceuticals Streptokinase Product Portfolio
6.8.5 Aristo Pharmaceuticals Recent Developments/Updates
6.9 Neiss Labs
6.9.1 Neiss Labs Corporation Information
6.9.2 Neiss Labs Description and Business Overview
6.9.3 Neiss Labs Streptokinase Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Neiss Labs Streptokinase Product Portfolio
6.9.5 Neiss Labs Recent Developments/Updates
6.10 Ahaan Healthcare Pvt Ltd. (AHPL)
6.10.1 Ahaan Healthcare Pvt Ltd. (AHPL) Corporation Information
6.10.2 Ahaan Healthcare Pvt Ltd. (AHPL) Description and Business Overview
6.10.3 Ahaan Healthcare Pvt Ltd. (AHPL) Streptokinase Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ahaan Healthcare Pvt Ltd. (AHPL) Streptokinase Product Portfolio
6.10.5 Ahaan Healthcare Pvt Ltd. (AHPL) Recent Developments/Updates
6.11 Biofactor
6.11.1 Biofactor Corporation Information
6.11.2 Biofactor Streptokinase Description and Business Overview
6.11.3 Biofactor Streptokinase Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Biofactor Streptokinase Product Portfolio
6.11.5 Biofactor Recent Developments/Updates
6.12 TTK HealthCare
6.12.1 TTK HealthCare Corporation Information
6.12.2 TTK HealthCare Streptokinase Description and Business Overview
6.12.3 TTK HealthCare Streptokinase Sales, Revenue and Gross Margin (2019-2024)
6.12.4 TTK HealthCare Streptokinase Product Portfolio
6.12.5 TTK HealthCare Recent Developments/Updates
6.13 Incepta Pharmaceuticals Limited
6.13.1 Incepta Pharmaceuticals Limited Corporation Information
6.13.2 Incepta Pharmaceuticals Limited Streptokinase Description and Business Overview
6.13.3 Incepta Pharmaceuticals Limited Streptokinase Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Incepta Pharmaceuticals Limited Streptokinase Product Portfolio
6.13.5 Incepta Pharmaceuticals Limited Recent Developments/Updates
6.14 Cadila
6.14.1 Cadila Corporation Information
6.14.2 Cadila Streptokinase Description and Business Overview
6.14.3 Cadila Streptokinase Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Cadila Streptokinase Product Portfolio
6.14.5 Cadila Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Streptokinase Industry Chain Analysis
7.2 Streptokinase Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Streptokinase Production Mode & Process
7.4 Streptokinase Sales and Marketing
7.4.1 Streptokinase Sales Channels
7.4.2 Streptokinase Distributors
7.5 Streptokinase Customers
8 Streptokinase Market Dynamics
8.1 Streptokinase Industry Trends
8.2 Streptokinase Market Drivers
8.3 Streptokinase Market Challenges
8.4 Streptokinase Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
